{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T05:53:28Z","timestamp":1777960408721,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000038","name":"NSERC","doi-asserted-by":"publisher","award":["RGPIN-2016-05867"],"award-info":[{"award-number":["RGPIN-2016-05867"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["335447717-SFB 1328"],"award-info":[{"award-number":["335447717-SFB 1328"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.bioorg.2023.106460","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T20:33:16Z","timestamp":1678480396000},"page":"106460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Synthesis and structure\u2013activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39"],"prefix":"10.1016","volume":"135","author":[{"given":"Chunyang","family":"Bi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Sch\u00e4kel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salahuddin","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Sylvester","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Yong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanigaimalai","family":"Pillaiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"S\u00e9vigny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0013-6624","authenticated-orcid":false,"given":"Christa E.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2023.106460_b0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","article-title":"Cellular function and molecular structure of ecto-nucleotidases","volume":"8","author":"Zimmermann","year":"2012","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bioorg.2023.106460_b0010","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s11302-006-9003-5","article-title":"The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance","volume":"2","author":"Robson","year":"2006","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bioorg.2023.106460_b0015","doi-asserted-by":"crossref","first-page":"pe6","DOI":"10.1126\/scisignal.256pe6","article-title":"Extracellular ATP in the immune system: More than just a \u201cdanger signal\u201d","volume":"2","author":"Trautmann","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.bioorg.2023.106460_b0020","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioorg.2023.106460_b0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0197-0186(98)00025-4","article-title":"ATP released by LPS increases nitric oxide production in raw 264.7 macrophage cell line via P2Z\/P2X7 receptors","volume":"33","author":"Sperl\u00e1gh","year":"1998","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bioorg.2023.106460_b0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2004.02.004","article-title":"Potent effect of interleukin-1\u03b2 to evoke ATP and adenosine release from rat hippocampal slices","volume":"151","author":"Sperl\u00e1gh","year":"2004","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bioorg.2023.106460_b0035","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11302-006-9050-y","article-title":"CD39 and control of cellular immune responses","volume":"3","author":"Dwyer","year":"2007","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bioorg.2023.106460_b0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-385526-8.00010-2","article-title":"Ectonucleotidases as regulators of purinergic signaling in thrombosis, inflammation, and immunity","volume":"61","author":"Deaglio","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0045","first-page":"358","article-title":"CD39 is the dominant Langerhans cell \u2013 associated ecto- NTPDase: modulatory roles in inflammation and immune responsiveness","volume":"8","author":"Mizumoto","year":"2002","journal-title":"Nature."},{"key":"10.1016\/j.bioorg.2023.106460_b0050","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ccell.2019.10.007","article-title":"Adenosine metabolism: emerging concepts for cancer therapy","volume":"36","author":"Boison","year":"2019","journal-title":"Cancer Cell."},{"key":"10.1016\/j.bioorg.2023.106460_b0055","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/B978-0-12-385526-8.00009-6","article-title":"Impact of ectoenzymes on P2 and P1 receptor signaling","volume":"61","author":"Kukulski","year":"2011","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00109-012-0988-7","article-title":"Transcriptional control of adenosine signaling by hypoxia-inducible transcription factors during ischemic or inflammatory disease","volume":"91","author":"Poth","year":"2013","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bioorg.2023.106460_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuropharm.2015.12.001","article-title":"Medicinal chemistry of adenosine, P2Y and P2X receptors","volume":"104","author":"Jacobson","year":"2016","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.bioorg.2023.106460_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.molmed.2013.03.005","article-title":"CD39 and CD73 in immunity and inflammation","volume":"19","author":"Antonioli","year":"2013","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bioorg.2023.106460_b0075","doi-asserted-by":"crossref","first-page":"e1002110","DOI":"10.1371\/journal.ppat.1002110","article-title":"CD39\/adenosine pathway is involved in AIDS progression","volume":"7","author":"Nikolova","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2023.106460_b0080","doi-asserted-by":"crossref","first-page":"e34730","DOI":"10.1371\/journal.pone.0034730","article-title":"Resident cardiac immune cells and expression of the ectonucleotidase enzymes CD39 and CD73 after ischemic injury","volume":"7","author":"B\u00f6nner","year":"2012","journal-title":"PLoS One."},{"key":"10.1016\/j.bioorg.2023.106460_b0085","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/onc.2012.269","article-title":"ENTPD1\/CD39 is a promising therapeutic target in oncology","volume":"32","author":"Bastid","year":"2013","journal-title":"Oncogene."},{"key":"10.1016\/j.bioorg.2023.106460_b0090","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/onci.1.1.18068","article-title":"CD73 promotes tumor growth and metastasis","volume":"1","author":"Zhang","year":"2012","journal-title":"Oncoimmunology."},{"key":"10.1016\/j.bioorg.2023.106460_b0095","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/473712","article-title":"Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape","volume":"2012","author":"Ghiringhelli","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.bioorg.2023.106460_b0100","first-page":"254","article-title":"Inhibition of CD39 enzymatic function at the surface of tumor cells alleviates their immunosuppressive activity, Cancer","volume":"3","author":"Bastid","year":"2015","journal-title":"Immunol. Res."},{"key":"10.1016\/j.bioorg.2023.106460_b0105","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12528","article-title":"The ectonucleotidases CD39 and CD73: Novel checkpoint inhibitor targets","volume":"276","author":"Allard","year":"2017","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bioorg.2023.106460_b0110","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.coph.2016.06.009","article-title":"A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1\u03b1 driven immunosuppression and improve immunotherapies of cancer","volume":"29","author":"Hatfield","year":"2016","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0115","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/bph.15299","article-title":"Update of P2X receptor properties and their pharmacology: IUPHAR Review 30","volume":"178","author":"Illes","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0120","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/bph.15005","article-title":"Update of P2Y receptor pharmacology: IUPHAR Review 27","volume":"177","author":"Jacobson","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0125","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s40778-018-0141-9","article-title":"Peripheral blood stem cell mobilization: a look ahead","volume":"4","author":"Pelus","year":"2018","journal-title":"Curr. Stem Cell Reports."},{"key":"10.1016\/j.bioorg.2023.106460_b0130","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s12015-019-09918-y","article-title":"The inhibition of CD39 and CD73 cell surface ectonucleotidases by small molecular inhibitors enhances the mobilization of bone marrow residing stem cells by decreasing the extracellular level of adenosine","volume":"15","author":"Adamiak","year":"2019","journal-title":"Stem Cell Rev. Reports."},{"key":"10.1016\/j.bioorg.2023.106460_b0135","doi-asserted-by":"crossref","first-page":"e0140996","DOI":"10.1371\/journal.pone.0140996","article-title":"Ecto-5\u2019-nucleotidase overexpression reduces tumor growth in a xenograph medulloblastoma model","volume":"10","author":"Capellari","year":"2015","journal-title":"PLos One"},{"key":"10.1016\/j.bioorg.2023.106460_b0140","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/bph.12135","article-title":"8-BuS-ATP derivatives as specific NTPDase1 inhibitors","volume":"169","author":"Lecka","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0145","doi-asserted-by":"crossref","unstructured":"B.E. Crack, C.E. Pollard, M.W. Beukers, S.M. Roberts, S.F. Hunt, A.H. Ingall, K.C. McKechnie, A.P. IJzerman, P. Leff, Pharmacological and biochemical analysis of FPL 67156, a novel, selective inhibitor of ecto-ATPase, Br. J. Pharmacol. 114 (1995) 475\u2013481. https:\/\/doi.org\/10.1111\/j.1476-5381.1995.tb13251.x.","DOI":"10.1111\/j.1476-5381.1995.tb13251.x"},{"key":"10.1016\/j.bioorg.2023.106460_b0150","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/sj.bjp.0707361","article-title":"Specificity of the ecto-ATPase inhibitor ARL 67156 on human and mouse ectonucleotidases","volume":"152","author":"L\u00e9vesque","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0155","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.3389\/fphar.2020.01294","article-title":"Nucleotide analog ARL67156 as a lead structure for the development of CD39 and dual CD39\/CD73 ectonucleotidase inhibitors","volume":"11","author":"Sch\u00e4kel","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0160","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11302-008-9103-5","article-title":"Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases)","volume":"5","author":"Baqi","year":"2009","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bioorg.2023.106460_b0165","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3389\/fphar.2020.01282","article-title":"Development of anthraquinone derivatives as ectonucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors with selectivity for NTPDase2 and NTPDase3","volume":"11","author":"Baqi","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/md19020051","article-title":"Sulfated polysaccharides from macroalgae are potent dual inhibitors of human ATP-hydrolyzing ectonucleotidases NPP1 and CD39","volume":"19","author":"Lopez","year":"2021","journal-title":"Mar. Drugs."},{"key":"10.1016\/j.bioorg.2023.106460_b0175","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1016\/j.bmcl.2006.09.003","article-title":"Polyoxometalates - a new class of potent ecto-nucleoside triphosphate diphosphohydrolase (NTPDase) inhibitors","volume":"16","author":"M\u00fcller","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2023.106460_b0180","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bcp.2014.11.002","article-title":"Polyoxometalates - potent and selective ecto-nucleotidase inhibitors","volume":"93","author":"Lee","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.585876","article-title":"Functionalized oxoindolin hydrazine carbothioamide derivatives as highly potent inhibitors of nucleoside triphosphate diphosphohydrolases","volume":"11","author":"Afzal","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/jitc-2022-004660","article-title":"Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 - a promising target for cancer immunotherapy","volume":"10","author":"Sch\u00e4kel","year":"2022","journal-title":"J. Immunother. Cancer."},{"key":"10.1016\/j.bioorg.2023.106460_b0195","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/j.1476-5381.2010.00951.x","article-title":"Inhibition of vascular ectonucleotidase activities by the pro-drugs ticlopidine and clopidogrel favours platelet aggregation","volume":"161","author":"Lecka","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2023.106460_b0200","doi-asserted-by":"crossref","first-page":"e2100300","DOI":"10.1002\/ardp.202100300","article-title":"2-Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors","volume":"354","author":"Sch\u00e4kel","year":"2021","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.bioorg.2023.106460_b0205","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.drudis.2018.09.021","article-title":"Antithrombotic P2Y 12 receptor antagonists: recent developments in drug discovery","volume":"24","author":"Baqi","year":"2019","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.bioorg.2023.106460_b0210","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/547480","article-title":"Ticlopidine in its prodrug form is a selective inhibitor of human NTPDase1","volume":"2014","author":"Lecka","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.bioorg.2023.106460_b0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1039\/P19730000205","article-title":"Conformational behaviour of medium-sized rings. part I. 5,6,11,12- tetrahydrodibenzo[a,e]cyclo-octene(1,2,5,6-dibenzocyclo-octa-1,5-diene) and heterocyclic analogues","volume":"1","author":"Crossley","year":"1973","journal-title":"J. Chem. Soc., Perkin Trans."},{"key":"10.1016\/j.bioorg.2023.106460_b0220","first-page":"107","article-title":"Synthesis of nucleobase-functionalized morpholino monomers","volume":"2019","author":"Nandi","year":"1973","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bioorg.2023.106460_b0225","doi-asserted-by":"crossref","first-page":"5614","DOI":"10.1021\/acs.joc.9b00566","article-title":"Application of the Suzuki-Miyaura reaction for the postfunctionalization of the benzo[4,5]thiazolo[3,2-c][1,3,5,2]oxadiazaborinine core: an approach toward fluorescent dyes","volume":"84","author":"Potopnyk","year":"2019","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2023.106460_b0230","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1080\/10286020.2017.1323885","article-title":"Bioactivity-guided synthesis of gramine derivatives as new MT1 and 5-HT1A receptors agonists","volume":"19","author":"Yin","year":"2017","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2023.106460_b0235","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1006\/abio.1999.4100","article-title":"A robotics-based automated assay for inorganic and organic phosphates","volume":"271","author":"Cogan","year":"1999","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2023.106460_b0240","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-4165(96)00079-7","article-title":"Purification of the blood vessel ATP diphosphohydrolase, identification and localisation by immunological techniques","volume":"1334","author":"S\u00e9vigny","year":"1997","journal-title":"Biochim. Biophys. Acta - Gen. Subj."},{"key":"10.1016\/j.bioorg.2023.106460_b0245","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11302-005-6217-x","article-title":"Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8","volume":"1","author":"Kukulski","year":"2005","journal-title":"Purinergic Signal."},{"key":"10.1016\/j.bioorg.2023.106460_b0250","doi-asserted-by":"crossref","unstructured":"R.A. Copeland, Enzymes: A Practical Introduction to Structure, Mechanism, and Data Analysis, second edition, Wiley\u2010VCH, Inc., 2000, doi: 10.1002\/0471220639.","DOI":"10.1002\/0471220639"},{"key":"10.1016\/j.bioorg.2023.106460_b0255","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ab.2013.10.012","article-title":"A new, sensitive ecto-5\u2019-nucleotidase assay for compound screening","volume":"446","author":"Freundlieb","year":"2014","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2023.106460_b0260","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1002\/ijc.29095","article-title":"Inhibition of glioma progression by a newly discovered CD38 inhibitor","volume":"136","author":"Blacher","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2023.106460_b0265","doi-asserted-by":"crossref","first-page":"33116","DOI":"10.1074\/jbc.271.51.33116","article-title":"Identification and characterization of CD39\/vascular ATP diphosphohydrolase","volume":"271","author":"Kaczmarek","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2023.106460_b0270","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.abb.2003.08.007","article-title":"Enzymatic and transcriptional regulation of human ecto-ATPase\/E-NTPDase 2","volume":"418","author":"Knowles","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2023.106460_b0275","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0167-4838(98)00063-6","article-title":"Cloning, sequencing, and expression of a human brain ecto-apyrase related to both the ecto-ATPases and CD39 ecto-apyrases","volume":"1386","author":"Smith","year":"1998","journal-title":"Biochim. Biophys. Acta - Protein Struct. Mol. Enzymol."},{"key":"10.1016\/j.bioorg.2023.106460_b0280","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1152\/ajpgi.00293.2006","article-title":"Cloning, purification, and identification of the liver canalicular ecto-ATPase as NTPDase8","volume":"292","author":"Fausther","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.bioorg.2023.106460_b0285","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1021\/acs.jmedchem.9b00164","article-title":"Structure-activity relationship of purine and pyrimidine nucleotides as ecto-5\u2032-nucleotidase (CD73) inhibitors","volume":"62","author":"Junker","year":"2019","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823001207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206823001207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T11:56:47Z","timestamp":1777463807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206823001207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"alternative-id":["S0045206823001207"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106460","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and structure\u2013activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2023.106460","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106460"}}